Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression

Figure 2

Signaling mechanism by which kallistatin inhibits EndMT by preventing the TGF-β-induced miR-21-Akt-NF-κB pathway and oxidative stress and stimulating eNOS/SIRT1 expression in endothelial cells.